REG - Uniphar PLC - Notice of AGM & Annual Report

UnipharAnnouncement

03/04/2025 07:04

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250403:nRSC4079Da&default-theme=true

RNS Number : 4079D  Uniphar PLC  03 April 2025

 

 

Publication of Notice of Annual General Meeting and Annual Report

 

 

Dublin, London | 3 April 2025: Uniphar plc (the "Company" or "Uniphar") wishes
to announce that it is today posting to shareholders its Notice of Annual
General Meeting ("AGM") for 2025 together with its annual report and accounts
for the year ended 31 December 2024 ("Annual Report"). The AGM will be held at
11.00 a.m. on 8 May 2025 at the offices of William Fry LLP, 2 Grand Canal
Square, Dublin 2, D02 A342.

Uniphar values the participation of its shareholders at its AGM and encourages
all shareholders to take part in the meeting either in person or by voting and
raising questions in advance.

The Notice of Meeting, Form of Proxy and Annual Report are available to view
on the Company's website at https://www.uniphar.ie/static/investors
(https://www.uniphar.ie/static/investors/shareholder-centre/AGM)
/shareholder-centre/AGM
(https://www.uniphar.ie/static/investors/shareholder-centre/AGM) /AGM-2025 and
will be available for inspection during normal business hours on any business
day from today until the conclusion of the AGM at the registered office of the
Company.

Proxy voting can be carried out in advance of the AGM. Details of how to do so
are set out in further detail in the Notice of Meeting.

A conference call facility will be provided to allow shareholders to listen
live to the business of the AGM. Please note that you will not be able to use
this facility to vote, raise points or issues or ask questions. If you wish to
listen live to the AGM proceedings, you can register for the conference call
and receive participant log-in details at
https://www.uniphar.ie/static/investors/shareholder-centre/AGM/AGM-2025
(https://www.uniphar.ie/static/investors/shareholder-centre/AGM/AGM-2025) .
Shareholders availing of this facility should ensure to submit any votes in
advance of the meeting as it will not be possible to vote using the conference
call facility.

Shareholders are invited to submit questions in writing in advance of the
meeting either by email to companysecretary@uniphar.ie
(mailto:companysecretary@uniphar.ie) or by post to the Company Secretary,
Uniphar plc, 4045 Kingswood Road, Citywest Business Park, Co. Dublin, D24
V06K, Ireland. Questions must be received by 5 p.m. on 6 May 2025.
Shareholders must include their Shareholder Reference Number (as set out on
their Form of Proxy) with any question submitted.

Contact details

 Uniphar Group                                            Tel: +353 (0) 1 428 7777

 Allan Smylie, Head of Strategy and IR

 Davy (Joint Corporate Broker, Nominated Advisor and      Tel: +353 (0) 1 679 6363

 Euronext Growth Listing Sponsor)

 Daragh O'Reilly

 Niall Gilchrist

 Ivan Murphy

 RBC Capital Markets (Joint Corporate Broker)             Tel: +44 (0) 20 7653 4000

 Jamil Miah

 Rupert Walford

 Stifel Nicolaus Europe Limited (Joint Corporate Broker)  Tel: +44 (0) 20 7710 7600

 Matt Blawat

 Ben Maddison

 Francis North

 Q4 PR                                                    Tel: +353 (0) 1 475 1444

 Iarla Mongey, Public Relations Advisor to Uniphar Group

 

About Uniphar plc

Headquartered in Dublin, Ireland, the Uniphar Group is an international
diversified healthcare services business servicing the requirements of more
than 200 multinational pharmaceutical and medical technology manufacturers
across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply
Chain & Retail. The Group is active in Europe, North America, APAC and
MENA and delivers to 160+ countries.

The Company's vision is to improve patient access to pharmaco-medical products
and treatments by enhancing connectivity between manufacturers and healthcare
stakeholders. Uniphar represents a strong combination of scale, growth, and
profitability.

Uniphar Supply Chain & Retail

Uniphar Supply Chain & Retail is the leading pharmaceutical wholesaler in
Ireland with a growing symbol group offering of retail pharmacies. The Group's
strategy for Uniphar Supply Chain & Retail is to grow our wholesale market
share, our symbol group network and our own brand, in-licenced and consumer
products portfolio.

Uniphar Medtech

Uniphar Medtech is a leading Pan-European medical device distributor and
solutions partner. The Group's strategy for Uniphar Medtech is to grow our
service offering across Europe and expand our addressable market by serving
new specialities and new manufacturers.

Uniphar Pharma

Uniphar Pharma operates a global business with high value services across the
lifecycle of a pharmaceutical product. We enable pharma and biotech companies
to bring innovative medicines to global markets and provide healthcare
professionals with access to medicines they can't source through traditional
channels. Our strategy is to build a leading platform to provide the
specialist support and expertise needed to improve access to these medicines.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAITMATMTMMBMA